| Tag | Content |
|---|
EnhancerAtlas ID | HS103-10070 |
Organism | Homo sapiens |
Tissue/cell | HUES64 |
Coordinate | chr17:39831350-39833140 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| PROP1 | MA0715.1 | chr17:39832058-39832069 | TAATCAAATTA | + | 6.02 | | Pou2f3 | MA0627.1 | chr17:39832061-39832077 | TCAAATTAGCATAAGA | - | 6.14 | | TFAP4 | MA0691.1 | chr17:39832020-39832030 | AACAGCTGAT | + | 6.02 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_10365 | chr17:39831891-39833405 | CD19_Primary | | SE_11484 | chr17:39830806-39833985 | CD20 | | SE_20177 | chr17:39832135-39833270 | CD56 | | SE_53687 | chr17:39832644-39833242 | Spleen |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr17 | 39832600 | 39832800 | | chr17 | 39832714 | 39833014 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I041674 | chr17 | 39831155 | 39836766 |
|
Enhancer Sequence | GGATCTAAGC AAGTTAAGAC TTTTGAGATA TGGGGTGTGT GTGCATTTGT GTGTGTGTGT 60
GTGTGTGTAA ATGCCCTCCC CCACCTCTTT CAGGGGTCAC TGAGTAAAGT TTACATCACT 120
CACACTGAAG CTGTCCTCAC AAGTTTGACA AAAACTCTGG ATAGGAATAC AGGTATAATT 180
AAGCATTAAT CGGGCTGCTC TTTGGCCCAG TTCCTTGTAA CCTAAAATCA CCTAACACTC 240
AGTACTGAAC ATCTGCATTT CCATGTTCCT ACAGATAGGA TCTCTGACAT TAGAATCATG 300
AGACTTCTGT TTAAGAATTG CTGAAGATGG CCAGGTGTGT TGGCTCATGT CTATAATCCC 360
AGCACTTTGG GAGGCCGAGG TGGGTGGATC ACCTGAGGTC AGGAGTTTGA GACCAGCCTG 420
GCCAACACAG AGAAACCCCA TCTCTACAAA AATACAAAAA TTAGTTGGGC ATGGTGGTGC 480
ATGCCTGTAA TCCCAGCTAC TAGAGAGGCT GAGGCAGGAG AATTGCTGGA ACCCGGGAGG 540
CGGAGGTTGT AGTGAGCCCA GATTGCATCA TTGCACTCCA GCCTGGGTGA CAGAGTGAGA 600
ATCTGTCTCA AAAAAAAAAA AAAAAAAAAA AAATTGCTGA AGATGTTTCT CCAATCCTGA 660
ATTCCAATGG AACAGCTGAT GCCAACCAGT TTGAAGGTTC CCACGGAGTA ATCAAATTAG 720
CATAAGAATG CAGTTTCTTC ATTTCCCTGT AGGTGAATTC ACCTTGCACC AATCAATGAT 780
CAGTTCCCTC CAAAACCCTT AAAATTCCTA GCCCCAAACT CCTCAGGGAG ATGGATTTGA 840
GGTTTCCTCT GGTCTCCTCA TTCAGCAGCC CTACAATTAA GCCTCTTTCT CTGCTACAAC 900
CCAGTATCTC AGTTACTGGC TTTCCATATG CACATCGAGC AATAAACCTA CTACGGTTAT 960
AACTTGTGTT TTAAGTGAAA ATGAATTCTT TGGGGAGACT GTGAAGAGCT GCCGAGGACT 1020
GCACACAGAC TGACACAGCA CAGAGCAAAG GGAGCCTCAA AGAATTTGGT GTCTTCATAA 1080
ATCTACACAA AACCAGATGG AAAGAGGCCA GAATGGGTCC TGGTCATCTC TGGGTGGTGA 1140
CTGATTTAAC AGGTGATTTT TTGGTTGCTT TGCGACTTTT TAATTTTTTA TGCAACAGGC 1200
ATTGCGATAT TGAGATATGA TATGAAAAGT TGTTTGATAT TGGTCCCCAG TTCCTGGCAC 1260
AGAGCCCTAA TGTAATATAA TAAATTAATA TTTGTCTTTT GTCCCCAGCT CTTGAAATAT 1320
CCCTGGAGCA ACAAAAGTTA AAGGAACATC TTTTGTTATC AAAACAAGCC TGTTTCAACC 1380
ACACAGGAGT TTAAGTTAAT GAGTGACTTT TGGAAAGCCC CTAAGGAGGG GGGCTGGATG 1440
CCAGGGGAAC CAAGCATGTG ATTAGAGAAG TAGAACTTTC AGCCCCACCT CCTGGCCTCT 1500
GGGGAGGGAA GAGAGGCTTG AGATTGAGTT TAATCACCAA GGGCCAATGA TGTAATCAAC 1560
CATGCCTACA TAATGGAAGC ACCATAAAAA CCCAAAGGAC CCATCAAGGT GTTGGGAGGA 1620
TGGTGCACCC GAAAGCACGT CAAAGCTCCC CACACTTCTC CACACCTCAC CCTGTGCGTC 1680
TCCTCCATCC TGCCAGGTTT GTTTTGTTGT TGTTGTTGTT GTTGTTGTTT GTTTTGTTGT 1740
TGTTGTTAAG AAGGAGTCTG GCTCTGTTGC CAGGCTGGAA TGCAGTGGAG 1790
|
